Merck Maintains Opposition to Uninjured Plaintiffs' Medical Monitoring Claims

NEW ORLEANS - Merck & Co. Inc. has asserted that a New Jersey appellate court's recent decision to reverse dismissal of a putative Vioxx medical monitoring class action does not undermine the company's arguments in the federal MDL that uninjured Vioxx plaintiffs may not sustain medical monitoring claims under state law. In Re: Vioxx Products Liability Litigation, MDL No. 1657 (E.D. La.).

Merck responded on Jan. 19 in the U.S. District Court for the Eastern District of Louisiana to the Plaintiffs' Steering Committee's submission as supplemental authority the New Jersey Appellate Division's Jan. 16 ruling in Sinclair, et al. v. …